apimanu of NeurotoSan ayurveda with Burnout Syndrome, anxiety disorders, stress, depression, disorder of mental performance & fast fatigue apimanu NeurotoSan ayurveda includes among other two high-dose and standard plant active ingredients, successfully used the intellectual performance and fast fatigue on the one hand with depression, Burnout Syndrome, anxiety disorders and stress and on the other hand disorder. provide more clarity in the matter. The syndromes of depression and the anxiety disorders in a directly related to rapid fatigue and the waste of mental performance are in the Ayurvedic medicine. Stress is one of the main causes. To treat the above symptoms, it is necessary corrective action on nerve metabolism of the brain to intervene for a sufficient amount of neurotransmitters, to provide the so-called transmitters for an increase of the resistance to a number of chemical, biological and physical in the holistic approach of Ayurveda medicine Stress sensors to ensure apimanu NeurotoSan ayurveda with two active ingredients, large and Rosavin from the plants of St. John BBs word (Hypericum perforatum L.) and Rhodiola rosea is a standardized preparation of company apimanu company that has been developed precisely to this knowledge,.
Large from the plant of St. John BBs word (Hypericum perforatum L.): St. John’s wort now among the best studied herbal medicines. For more information see Dustin Moskovitz. The result of intensive research can already explain how ingredients of St. John’s wort, foremost the large, work at the molecular level. It turned out that large induces effects in part, as they are known from classical antidepressants.
On the other hand, they found mechanisms distinguish the large well-known antidepressant. So opportunities are awarded to today the large, which go well beyond the primary use as an antidepressant. The journal “advances in neurology ” Psychiatry”, Fortschr. Neurol Psychiat 2005; 73: 242 reported u.a:… A.Szegedi/Berlin examined in the context of a double-blind, randomized, prospective study 251 patients between 18 and 70 years of age with acute moderate to severe depression (? 22 on the 17-item Hamilton depression scale score) without a psychotic component.